31 Reasons To Reject The Jab
- Thread starter Jefferson
- Start date
Most of my life I was a very trusting person. So many reasons now not to trust ... but depend on the LORD God to have given us the truth even about how wrong multiple sexual encounters are stupid.
I trusted any vaccine that was offered. The first time I felt mistrust was when I had to have a flu shot to enter college. I did not want to take it but did because my college required it.
Now, I am very concerned about all the vaccines that are given to our babies! About what these might be doing to our children as they grow. We have so many emotionally challenged children these days. Something has caused it. I thank Mr. Kennedy for stepping up to try to solves some of the harmful things we are taking into our bodies. May our Lord be with him. Amen.
I trusted any vaccine that was offered. The first time I felt mistrust was when I had to have a flu shot to enter college. I did not want to take it but did because my college required it.
Now, I am very concerned about all the vaccines that are given to our babies! About what these might be doing to our children as they grow. We have so many emotionally challenged children these days. Something has caused it. I thank Mr. Kennedy for stepping up to try to solves some of the harmful things we are taking into our bodies. May our Lord be with him. Amen.
Even the flu? That one never made sense.
way 2 go
Well-known member
☕️ THE HARD WAY ☙ Saturday, January 10, 2026 ☙ C&C NEWS 🦠
Trump hammers credit-card usury; markets jump on a mortgage-bond tweet; tariff & tax refunds teased; affordability EO for homebuyers; PBS cuts news; Greenland threat hardens; & cancer study detonates.
substack.com
Dropbox
www.dropbox.com
The newly published (January 3rd), peer-reviewed study in Oncotarget does something that was functionally forbidden for four years: it systematically catalogs cancer cases temporally associated with covid vaccination and covid infection, then asks —carefully, explicitly— whether mRNA might plausibly connect the dots.
The first reason is that the study’s authors aren’t fringe figures or Twitter gadflies. Dr. Charlotte Kuperwasser is a senior cancer biologist at Tufts University whose work focuses on tumor microenvironments, metastasis, and immune–cancer interactions. Dr. Wafik S. El-Deiry is a longtime oncologist and molecular cancer researcher at Brown University, former president of the American Association for Cancer Research, and a leading authority on p53 signaling and cancer therapeutics.
In other words, these are scientists whose day jobs are spotting early cancer signals— not making them up for clicks. And they know the game. The paper took a year to traverse peer review and be published— including 5 months of silence following acceptance.
The second, and perhaps bigger reason, is that the two researchers didn’t conduct a new experiment that could be sliced and diced by Big Pharma’s stable of pet critics. Instead, they reviewed 69 other peer-reviewed publications from 27 different countries, covering 333 patients, plus several large population-level datasets, and proved recurring patterns that simply cannot be waved away:
- unusually rapid cancer progression,
- reactivation of previously controlled disease,
- odd tumor clusters near injection sites or draining lymph nodes, and
- a striking overrepresentation of lymphomas, leukemias, aggressive solid tumors, and virus-associated cancers.
Iconoblast
New member
Earlier in the thread someone emphasized that 80% of pediatric flu deaths were among the unvaccinated.
Without doing due diligence, I know it is from cooking the books.
That is from late in 2021. When "covid deaths" got really high, which was after tens of millions were vaccinated. And they were dying. And the politician for the CDC was trying to get ahead of the information. Without this anecdote, I know it isn't true.
Iconoblast
New member
Perhaps so. That would require a great deal of cooking. A multinational coverup involving hundreds of people.
Practice Guideline:
Pediatric influenza-related deaths range from 37 to 207 reported cases annually in recent seasons (excluding the 2020-2021 pandemic year), though the American Academy of Pediatrics notes these figures likely represent significant underreporting—statistical models suggest actual deaths may be 3-4 times higher than reported cases.[1]
The primary causes of death include direct viral complications and secondary bacterial infections. Neurologic complications occur in approximately 8-11% of hospitalized children, with influenza-associated encephalopathy or encephalitis (IAE) identified in 9% of pediatric deaths across multiple seasons.[1] Acute necrotizing encephalopathy (ANE), a severe form of IAE characterized by rapid neurologic deterioration and bilateral thalamic lesions, represents a particularly devastating complication.[1] Bacterial complications include bloodstream infections (occurring in 0.9% of hospitalized children), with Staphylococcus aureus and Streptococcus pneumoniae as the most common pathogens.[1] Invasive group A streptococcal infections have also been associated with influenza virus infection.[1]
Deaths occur in both previously healthy children and those with underlying conditions—approximately 45-51% of pediatric deaths occur in children without recognized high-risk medical conditions.[2] Among children with underlying conditions, asthma is the most common (27.1%), followed by neurologic disorders (17.7%).[2]
Historically, up to 80% of pediatric deaths have occurred in unvaccinated children aged 6 months and older who were eligible for vaccination.[2] Vaccination demonstrates 65% effectiveness against influenza-associated death overall, and 51% effectiveness in children with underlying medical conditions.[2] The American Academy of Pediatrics emphasizes that most deaths (70%) in vaccine-eligible children occurred in those who were unvaccinated.[2]
Severe outcomes, including in-hospital death, are highest in adolescents 13-17 years of age in multivariable models.[3][4] Racial and ethnic disparities are pronounced, with in-hospital death rates 3-4 fold higher in Black, Hispanic, and Asian or Pacific Islander children compared with white children.[4]
Population-based surveillance data from the Centers for Disease Control and Prevention's Influenza Hospitalization Surveillance Network over nine seasons (2010-2019) reveal that adjusted influenza-associated hospitalization incidence rates ranged from 10 to 375 per 100,000 persons each season, with the highest rates among infants under 6 months of age.[5] The in-hospital mortality rate was also highest in this youngest age group at 0.73 per 100,000 persons.[5] Among 13,235 hospitalized children during this period, 72 (0.5%) died during hospitalization, with older children (≥13 years) having 3.3 times higher odds of death compared to infants under 6 months.[5]
Analysis of 675 pediatric deaths reported from 2010-2016 found an average annual incidence of 0.15 per 100,000 children, with the highest rates in infants under 6 months (0.66 per 100,000) and children aged 6-23 months (0.33 per 100,000).[6] The median age at death was 6 years, and only 31% of vaccine-eligible children had received any influenza vaccination.[6] Rapid disease progression is characteristic—65% of children died within 7 days after symptom onset, and among previously healthy children, 77% died before hospital admission compared to 48% of those with underlying conditions.[6]
Australian surveillance over ten seasons (2008-2017) identified 613 children with severe influenza complications, of whom 30 died.[7] Children who died were more likely to be older (5-14 years), have underlying medical conditions, require ICU admission, and develop encephalitis, acute renal failure, or myocarditis.[7] Notably, influenza B was more frequently associated with specific complications including acute renal failure, rhabdomyolysis, myocarditis, pericarditis, and cardiomyopathy compared to influenza A.[7]
Recent surveillance through the 2024-25 season indicates that IAE was identified in 166 of 1,840 (9%) pediatric influenza-associated deaths, with proportions ranging from 0% to 14% across seasons.[8] Among children with fatal IAE, 54% had no underlying medical conditions and only 20% had received influenza vaccination.[8]
References
1. Recommendations for Prevention and Control of Influenza in Children, 2025-2026: Technical Report. Committee on Infectious Diseases. Pediatrics. 2025;:202846. doi:10.1542/peds.2025-073622.
2. Recommendations for Prevention and Control of Influenza in Children, 2019-2020. Pediatrics. 2019;144(4):e20192478. doi:10.1542/peds.2019-2478.
3. Recommendations for Prevention and Control of Influenza in Children, 2023-2024. Pediatrics. 2023;152(4):e2023063773. doi:10.1542/peds.2023-063773.
4. Recommendations for Prevention and Control of Influenza in Children, 2022-2023. Pediatrics. 2022;150(4):e2022059275. doi:10.1542/peds.2022-059275.
5. Epidemiology, Clinical Characteristics, and Outcomes of Influenza-Associated Hospitalizations in US Children Over 9 Seasons Following the 2009 H1N1 Pandemic. Kamidani S, Garg S, Rolfes MA, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2022;75(11):1930-1939. doi:10.1093/cid/ciac296.
6. Influenza-Associated Pediatric Deaths in the United States, 2010-2016. Shang M, Blanton L, Brammer L, Olsen SJ, Fry AM. Pediatrics. 2018;141(4):e20172918. doi:10.1542/peds.2017-2918.
7. Ten Years of National Seasonal Surveillance for Severe Complications of Influenza in Australian Children. Teutsch SM, Zurynski YA, Nunez C, et al. The Pediatric Infectious Disease Journal. 2021;40(3):191-198. doi:10.1097/INF.0000000000002961.
8. Reports of Encephalopathy Among Children With Influenza-Associated Mortality - United States, 2010-11 Through 2024-25 Influenza Seasons. Fazal A, Reinhart K, Huang S, et al. MMWR. Morbidity and Mortality Weekly Report. 2025;74(6):91-95. doi:10.15585/mmwr.mm7406a3.
Practice Guideline:
Pediatric influenza-related deaths range from 37 to 207 reported cases annually in recent seasons (excluding the 2020-2021 pandemic year), though the American Academy of Pediatrics notes these figures likely represent significant underreporting—statistical models suggest actual deaths may be 3-4 times higher than reported cases.[1]
The primary causes of death include direct viral complications and secondary bacterial infections. Neurologic complications occur in approximately 8-11% of hospitalized children, with influenza-associated encephalopathy or encephalitis (IAE) identified in 9% of pediatric deaths across multiple seasons.[1] Acute necrotizing encephalopathy (ANE), a severe form of IAE characterized by rapid neurologic deterioration and bilateral thalamic lesions, represents a particularly devastating complication.[1] Bacterial complications include bloodstream infections (occurring in 0.9% of hospitalized children), with Staphylococcus aureus and Streptococcus pneumoniae as the most common pathogens.[1] Invasive group A streptococcal infections have also been associated with influenza virus infection.[1]
Deaths occur in both previously healthy children and those with underlying conditions—approximately 45-51% of pediatric deaths occur in children without recognized high-risk medical conditions.[2] Among children with underlying conditions, asthma is the most common (27.1%), followed by neurologic disorders (17.7%).[2]
Historically, up to 80% of pediatric deaths have occurred in unvaccinated children aged 6 months and older who were eligible for vaccination.[2] Vaccination demonstrates 65% effectiveness against influenza-associated death overall, and 51% effectiveness in children with underlying medical conditions.[2] The American Academy of Pediatrics emphasizes that most deaths (70%) in vaccine-eligible children occurred in those who were unvaccinated.[2]
Severe outcomes, including in-hospital death, are highest in adolescents 13-17 years of age in multivariable models.[3][4] Racial and ethnic disparities are pronounced, with in-hospital death rates 3-4 fold higher in Black, Hispanic, and Asian or Pacific Islander children compared with white children.[4]
Population-based surveillance data from the Centers for Disease Control and Prevention's Influenza Hospitalization Surveillance Network over nine seasons (2010-2019) reveal that adjusted influenza-associated hospitalization incidence rates ranged from 10 to 375 per 100,000 persons each season, with the highest rates among infants under 6 months of age.[5] The in-hospital mortality rate was also highest in this youngest age group at 0.73 per 100,000 persons.[5] Among 13,235 hospitalized children during this period, 72 (0.5%) died during hospitalization, with older children (≥13 years) having 3.3 times higher odds of death compared to infants under 6 months.[5]
Analysis of 675 pediatric deaths reported from 2010-2016 found an average annual incidence of 0.15 per 100,000 children, with the highest rates in infants under 6 months (0.66 per 100,000) and children aged 6-23 months (0.33 per 100,000).[6] The median age at death was 6 years, and only 31% of vaccine-eligible children had received any influenza vaccination.[6] Rapid disease progression is characteristic—65% of children died within 7 days after symptom onset, and among previously healthy children, 77% died before hospital admission compared to 48% of those with underlying conditions.[6]
Australian surveillance over ten seasons (2008-2017) identified 613 children with severe influenza complications, of whom 30 died.[7] Children who died were more likely to be older (5-14 years), have underlying medical conditions, require ICU admission, and develop encephalitis, acute renal failure, or myocarditis.[7] Notably, influenza B was more frequently associated with specific complications including acute renal failure, rhabdomyolysis, myocarditis, pericarditis, and cardiomyopathy compared to influenza A.[7]
Recent surveillance through the 2024-25 season indicates that IAE was identified in 166 of 1,840 (9%) pediatric influenza-associated deaths, with proportions ranging from 0% to 14% across seasons.[8] Among children with fatal IAE, 54% had no underlying medical conditions and only 20% had received influenza vaccination.[8]
References
1. Recommendations for Prevention and Control of Influenza in Children, 2025-2026: Technical Report. Committee on Infectious Diseases. Pediatrics. 2025;:202846. doi:10.1542/peds.2025-073622.
2. Recommendations for Prevention and Control of Influenza in Children, 2019-2020. Pediatrics. 2019;144(4):e20192478. doi:10.1542/peds.2019-2478.
3. Recommendations for Prevention and Control of Influenza in Children, 2023-2024. Pediatrics. 2023;152(4):e2023063773. doi:10.1542/peds.2023-063773.
4. Recommendations for Prevention and Control of Influenza in Children, 2022-2023. Pediatrics. 2022;150(4):e2022059275. doi:10.1542/peds.2022-059275.
5. Epidemiology, Clinical Characteristics, and Outcomes of Influenza-Associated Hospitalizations in US Children Over 9 Seasons Following the 2009 H1N1 Pandemic. Kamidani S, Garg S, Rolfes MA, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2022;75(11):1930-1939. doi:10.1093/cid/ciac296.
6. Influenza-Associated Pediatric Deaths in the United States, 2010-2016. Shang M, Blanton L, Brammer L, Olsen SJ, Fry AM. Pediatrics. 2018;141(4):e20172918. doi:10.1542/peds.2017-2918.
7. Ten Years of National Seasonal Surveillance for Severe Complications of Influenza in Australian Children. Teutsch SM, Zurynski YA, Nunez C, et al. The Pediatric Infectious Disease Journal. 2021;40(3):191-198. doi:10.1097/INF.0000000000002961.
8. Reports of Encephalopathy Among Children With Influenza-Associated Mortality - United States, 2010-11 Through 2024-25 Influenza Seasons. Fazal A, Reinhart K, Huang S, et al. MMWR. Morbidity and Mortality Weekly Report. 2025;74(6):91-95. doi:10.15585/mmwr.mm7406a3.
way 2 go
Well-known member
and billions of dollars
The U.S. pharmaceutical industry generated $722.5 billion in revenue in 2023.
Healthcare and pharmaceutical advertising in the U.S. has consistently reached $30 billion annually,
The U.S. pharmaceutical industry generated significant profits in recent years, with the five largest U.S. pharmaceutical companies—Eli Lilly, Johnson & Johnson, Merck, AbbVie, and Pfizer—reporting combined net earnings of $81.9 billion in 2022, an increase of $8 billion from 2021.
for comparison
Ford Motor Company and General Motors (GM) are the top two automakers in the United States by revenue, with Ford reporting $177.49 billion and GM reporting $174.87 billion in revenue. Tesla follows closely with $94.74 billion in revenue.
In 2023, Tesla surpassed both Ford and GM in profitability among publicly traded American automakers, ranking seventh globally with $8.05 billion in earnings, compared to GM’s $7.01 billion and Ford’s $5.51 billion.
Attachments
Iconoblast
New member
What does the absolute dollar amount have to do with it? Are you implying bribes to clinical investigators and lobbying can cook the books of corrupt researchers, politicians, and pharma boards? Sure theoretically. For a while. Eventually the flat earth society meeting folds and the pyramid schemes topple.
Vaccine production and administration account for less than 1% of annual healthcare expenditure. Americans spend more on cosmetics. There are easier and less scrutinized ways to grift and graft.
All it would take is one hot dog PhD or MD to blow the lid off it and get super famous. Medical research is competitive and public. If I invent a vaccine that actually does work, would I be shot from a black helicopter? Come on. In a world like that I’d be scared to drink milk and use a cell phone.
Vaccine production and administration account for less than 1% of annual healthcare expenditure. Americans spend more on cosmetics. There are easier and less scrutinized ways to grift and graft.
All it would take is one hot dog PhD or MD to blow the lid off it and get super famous. Medical research is competitive and public. If I invent a vaccine that actually does work, would I be shot from a black helicopter? Come on. In a world like that I’d be scared to drink milk and use a cell phone.
Welcome to big pharma. Are you familiar with the cholesterol myth?
Cholesterol is made by your body (you were created). It builds and repairs cells. LDL, low density lippoprotein, is low density so it can pass through cell walls. Brain cells are rich in cholesterol. Guess what happens if you take a drug to stop LDL knowing the brain is made of it? You don't need a study, but here it is anyway. If you take a drug to stop production of what your brain is made of, your brain will die.
Yes, cooking the books has been going on for decades. It started at the beginning of the 20th century with quackery from Post and Kellogs. Read about it. And that is double the risk of people who get it and should not in the first place from American Metabolic Syndrome.